Moderna, Inc. (MRNA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 129.06 |
| Open | 129.77 |
| Bid | 132.64 x 100 |
| Ask | 132.73 x 200 |
| Day's Range | 127.83 - 133.04 |
| 52 Week Range | 62.55 - 142.79 |
| Volume | |
| Avg. Volume | 3,849,516 |
| Market Cap | 50.848B |
| Beta (5Y Monthly) | 1.57 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Novavax, Inc (NVAX) and Fulcrum Therapeutics, Inc (FULC) are in the spotlight following license agreements with pharma giant Sanofi.
- Investor's Business Daily
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Moderna is on the rise after the Food and Drug Administration delayed a decision on its RSV vaccine. But is MRNA stock, once again, a buy?
- Zacks
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Moderna's (MRNA) RSV vaccine, mRNA-1345's review timeline gets delayed. A decision is now expected by the end of May.
© 2024 Yahoo. All rights reserved.